FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3131111632> ?p ?o ?g. }

• W3131111632 abstract "Abstract Background While the epidemiologic association between hepatitis B virus (HBV) infection and diffuse large B-cell lymphoma (DLBCL) is established, little is known about the pathological characteristics and outcome of DLBCL arising in patients with HBV infection. Methods We retrospectively studied a cohort of 420 patients with DLBCL for the incidence of HBV infection, and the clinicopathologic features and prognostic factors in HBsAg-positive DLBCL patients in China, a hepatitis B endemic area. Results In our study, 127 (30.2%) patients were HBsAg-positive. HBsAg-positive DLBCL displayed a younger median onset age (50 vs. 54 years, P = 0.002), more frequent involvement of the spleen (19.7% vs. 6.1%, P < 0.001), less frequent involvement of the small and large intestine (2.3% vs. 11.2%, P = 0.003), more advanced disease (stage III/IV: 56.7% vs. 45.1%, P = 0.028), and lower expression rate of MYC (49.1% vs. 66.7%, P = 0.026). The median follow-up time was 61.9 months. Univariate analysis showed that there was no significant difference in overall survival (OS) between HBsAg-negative and -positive DLBCL ( P = 0.577). In the HBsAg-positive DLBCL subgroup, age older than 60 years, advanced disease, elevated lactate dehydrogenase (LDH), spleen involvement, B symptoms (fever, night sweats, weight loss), and double expressers of MYC and BCL2 had a significantly worse outcome, and patients treated with R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone) had a better prognosis. Multivariate analysis further confirmed that spleen involvement and rituximab use were independent prognostic factors in HBsAg-positive DLBCL patients. Conclusions Our study indicates that HBsAg-positive DLBCL has unique clinicopathological features and independent prognostic factors. Moreover, under antiviral prophylaxis, the survival of DLBCL patients with HBV infections was comparable to that of HBV-negative patients, and the use of rituximab significantly improved OS in HBsAg-positive DLBCL patients." @default.
• W3131111632 created "2021-03-01" @default.
• W3131111632 creator A5020933805 @default.
• W3131111632 creator A5021830408 @default.
• W3131111632 creator A5033411376 @default.
• W3131111632 creator A5040894870 @default.
• W3131111632 creator A5049070963 @default.
• W3131111632 creator A5064140041 @default.
• W3131111632 creator A5088877338 @default.
• W3131111632 creator A5090590965 @default.
• W3131111632 date "2021-08-17" @default.
• W3131111632 modified "2023-10-13" @default.
• W3131111632 title "Clinicopathological and prognostic features of hepatitis B virus-associated diffuse large B-cell lymphoma: a single-center retrospective study in China" @default.
• W3131111632 cites W1568269141 @default.
• W3131111632 cites W1903125330 @default.
• W3131111632 cites W1956749639 @default.
• W3131111632 cites W1965654962 @default.
• W3131111632 cites W1966282055 @default.
• W3131111632 cites W1979792611 @default.
• W3131111632 cites W2015686782 @default.
• W3131111632 cites W2015887202 @default.
• W3131111632 cites W2018071905 @default.
• W3131111632 cites W2023506702 @default.
• W3131111632 cites W2031730698 @default.
• W3131111632 cites W2060432539 @default.
• W3131111632 cites W2065004055 @default.
• W3131111632 cites W2087164555 @default.
• W3131111632 cites W2096596684 @default.
• W3131111632 cites W2128292516 @default.
• W3131111632 cites W2133253108 @default.
• W3131111632 cites W2144661425 @default.
• W3131111632 cites W2145453495 @default.
• W3131111632 cites W2152105625 @default.
• W3131111632 cites W2159503446 @default.
• W3131111632 cites W2310716991 @default.
• W3131111632 cites W2355542710 @default.
• W3131111632 cites W2725365539 @default.
• W3131111632 cites W2735446022 @default.
• W3131111632 cites W2753109199 @default.
• W3131111632 cites W2768821568 @default.
• W3131111632 cites W2792567388 @default.
• W3131111632 cites W2805387874 @default.
• W3131111632 cites W2949151892 @default.
• W3131111632 cites W3015593652 @default.
• W3131111632 cites W3015978027 @default.
• W3131111632 cites W3095947199 @default.
• W3131111632 cites W4253457069 @default.
• W3131111632 doi "https://doi.org/10.1186/s13027-021-00396-x" @default.
• W3131111632 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8369744" @default.
• W3131111632 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34404436" @default.
• W3131111632 hasPublicationYear "2021" @default.
• W3131111632 type Work @default.
• W3131111632 sameAs 3131111632 @default.
• W3131111632 citedByCount "4" @default.
• W3131111632 countsByYear W31311116322023 @default.
• W3131111632 crossrefType "journal-article" @default.
• W3131111632 hasAuthorship W3131111632A5020933805 @default.
• W3131111632 hasAuthorship W3131111632A5021830408 @default.
• W3131111632 hasAuthorship W3131111632A5033411376 @default.
• W3131111632 hasAuthorship W3131111632A5040894870 @default.
• W3131111632 hasAuthorship W3131111632A5049070963 @default.
• W3131111632 hasAuthorship W3131111632A5064140041 @default.
• W3131111632 hasAuthorship W3131111632A5088877338 @default.
• W3131111632 hasAuthorship W3131111632A5090590965 @default.
• W3131111632 hasBestOaLocation W31311116321 @default.
• W3131111632 hasConcept C126322002 @default.
• W3131111632 hasConcept C144301174 @default.
• W3131111632 hasConcept C203014093 @default.
• W3131111632 hasConcept C2522874641 @default.
• W3131111632 hasConcept C2776694085 @default.
• W3131111632 hasConcept C2776755627 @default.
• W3131111632 hasConcept C2777382497 @default.
• W3131111632 hasConcept C2777410769 @default.
• W3131111632 hasConcept C2778559949 @default.
• W3131111632 hasConcept C2779338263 @default.
• W3131111632 hasConcept C2779429289 @default.
• W3131111632 hasConcept C2780593183 @default.
• W3131111632 hasConcept C2780653079 @default.
• W3131111632 hasConcept C38180746 @default.
• W3131111632 hasConcept C71924100 @default.
• W3131111632 hasConcept C90924648 @default.
• W3131111632 hasConceptScore W3131111632C126322002 @default.
• W3131111632 hasConceptScore W3131111632C144301174 @default.
• W3131111632 hasConceptScore W3131111632C203014093 @default.
• W3131111632 hasConceptScore W3131111632C2522874641 @default.
• W3131111632 hasConceptScore W3131111632C2776694085 @default.
• W3131111632 hasConceptScore W3131111632C2776755627 @default.
• W3131111632 hasConceptScore W3131111632C2777382497 @default.
• W3131111632 hasConceptScore W3131111632C2777410769 @default.
• W3131111632 hasConceptScore W3131111632C2778559949 @default.
• W3131111632 hasConceptScore W3131111632C2779338263 @default.
• W3131111632 hasConceptScore W3131111632C2779429289 @default.
• W3131111632 hasConceptScore W3131111632C2780593183 @default.
• W3131111632 hasConceptScore W3131111632C2780653079 @default.
• W3131111632 hasConceptScore W3131111632C38180746 @default.
• W3131111632 hasConceptScore W3131111632C71924100 @default.
• W3131111632 hasConceptScore W3131111632C90924648 @default.
• W3131111632 hasFunder F4320321878 @default.
• W3131111632 hasIssue "1" @default.
• W3131111632 hasLocation W31311116321 @default.

• next